Global Enalapril
Market Report
2025
The global Enalapril market size will be USD xx million in 2024. Rising Prevalence of Cardiovascular Diseases is expected to boost sales to USD XX million by 2031, with a Compound Annual Growth Rate (CAGR) of 6.20% from 2024 to 2031.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Enalapril Market Report 2025.
According to Cognitive Market Research, the global Enalapril market size will be USD xx million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.20% from 2024 to 2031.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Enalapril Market Sales Revenue | $ 487.94 Million | $ 597.62 Million | $ 896.5 Million | 5.2% |
North America Enalapril Market Sales Revenue | $ 140 Million | $ 166.1 Million | $ 241.2 Million | 4.8% |
United States Enalapril Market Sales Revenue | $ 118.1 Million | $ 139.1 Million | $ 200.4 Million | 4.7% |
Canada Enalapril Market Sales Revenue | $ 16.5 Million | $ 20.2 Million | $ 30.1 Million | 5.1% |
Mexico Enalapril Market Sales Revenue | $ 5.5 Million | $ 6.9 Million | $ 10.6 Million | 5.5% |
Europe Enalapril Market Sales Revenue | $ 163.9 Million | $ 195.4 Million | $ 285.1 Million | 4.8% |
United Kingdom Enalapril Market Sales Revenue | $ 26.7 Million | $ 30.7 Million | $ 43 Million | 4.3% |
France Enalapril Market Sales Revenue | $ 23.6 Million | $ 27.4 Million | $ 38.8 Million | 4.5% |
Germany Enalapril Market Sales Revenue | $ 31.5 Million | $ 37 Million | $ 53.3 Million | 4.7% |
Italy Enalapril Market Sales Revenue | $ 17.5 Million | $ 21.5 Million | $ 32.2 Million | 5.2% |
Russia Enalapril Market Sales Revenue | $ 15.2 Million | $ 18.6 Million | $ 27.7 Million | 5.1% |
Spain Enalapril Market Sales Revenue | $ 14.1 Million | $ 17.1 Million | $ 25.4 Million | 5.1% |
Rest of Europe Enalapril Market Sales Revenue | $ 18.5 Million | $ 22.3 Million | $ 32.8 Million | 4.9% |
Luxembourg Enalapril Market Sales Revenue | $ 3.9 Million | $ 4.8 Million | $ 7.1 Million | 5.1% |
Asia Pacific Enalapril Market Sales Revenue | $ 121 Million | $ 158.7 Million | $ 253.7 Million | 6% |
China Enalapril Market Sales Revenue | $ 33.8 Million | $ 46.1 Million | $ 76.6 Million | 6.6% |
Japan Enalapril Market Sales Revenue | $ 23.4 Million | $ 30.1 Million | $ 47.4 Million | 5.8% |
India Enalapril Market Sales Revenue | $ 19.8 Million | $ 27.2 Million | $ 45.4 Million | 6.6% |
South Korea Enalapril Market Sales Revenue | $ 12.9 Million | $ 16.7 Million | $ 26.4 Million | 5.9% |
Australia Enalapril Market Sales Revenue | $ 9.2 Million | $ 11.8 Million | $ 18.5 Million | 5.8% |
Rest of APAC Enalapril Market Sales Revenue | 121212 | 121212 | 121212 | 8% |
South East Asia Enalapril Market Sales Revenue | $ 14.4 Million | $ 19 Million | $ 30.7 Million | 6.2% |
South America Enalapril Market Sales Revenue | 121212 | 121212 | 121212 | 5.6% |
Brazil Enalapril Market Sales Revenue | $ 14.5 Million | $ 18.3 Million | $ 28.1 Million | 5.5% |
Argentina Enalapril Market Sales Revenue | $ 7.9 Million | $ 10.3 Million | $ 16.4 Million | 6% |
Colombia Enalapril Market Sales Revenue | $ 5 Million | $ 6.6 Million | $ 10.8 Million | 6.3% |
Peru Enalapril Market Sales Revenue | $ 3 Million | $ 4.1 Million | $ 6.7 Million | 6.4% |
Chile Enalapril Market Sales Revenue | $ 2.6 Million | $ 3.4 Million | $ 5.4 Million | 6.1% |
Rest of South America Enalapril Market Sales Revenue | 121212 | 121212 | 121212 | 4.7% |
Middle East Enalapril Market Sales Revenue | 121212 | 121212 | 121212 | 5.9% |
Egypt Enalapril Market Sales Revenue | $ 5.2 Million | $ 6.1 Million | $ 8.9 Million | 4.7% |
Turkey Enalapril Market Sales Revenue | $ 3.9 Million | $ 4.8 Million | $ 7 Million | 5% |
Rest of Middle East Enalapril Market Sales Revenue | $ 1.2 Million | $ 1.2 Million | $ 1.4 Million | 2.2% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Dosage Form O |
|
Market Split by Application |
|
Market Split by Distribution Channel |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Enalapril industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Enalapril Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The enalapril marketplace refers back to the segment of the pharmaceutical enterprise targeted on the production, distribution, and income of enalapril, an angiotensin-changing enzyme (ACE) inhibitor used generally to deal with hypertension and coronary heart failure. It allows lower blood pressure and decreases the chance of cardiovascular events. The marketplace encompasses both branded and conventional variations of enalapril, pushed through elements consisting of the increasing occurrence of cardiovascular diseases, developing recognition of high blood pressure control, and the demand for cheap remedy options.
Rising Prevalence of Cardiovascular Diseases to Boost Market Growth: The global upward push in cardiovascular illnesses, which include hypertension and coronary heart failure, is basically pushed by means of lifestyle elements inclusive of sedentary conduct, dangerous diets, smoking, and strain. These conditions have become extra time-honored as urbanization and dangerous living patterns boom worldwide. This surge has brought about growing demand for antihypertensive medicines like enalapril, which assist control blood strain and decrease the danger of heart-associated headaches. With cardiovascular diseases being a main motive of morbidity and mortality, the want for powerful remedies continues to fuel the marketplace for medicinal drugs that can mitigate those conditions.
Increasing Awareness and Early Diagnosis to Drive Market Growth: Increased cognizance of cardiovascular risk elements, inclusive of excessive blood pressure, terrible food plans, and lack of physical activity, has brought about an advanced prognosis of conditions like high blood pressure. Public fitness campaigns and progressed access to healthcare have knowledgeable people approximately the significance of normal screenings and dealing with cardiovascular health. As a result, greater human beings are being identified within the early stages of hypertension, prompting a rise in the prescription of medications like enalapril to control blood strain and prevent headaches. This fashion contributes to the growing call for antihypertensive capsules, as early intervention will become extra, not unusual.
Generic Competition, will Limit Market Growth: The availability of customary versions of enalapril has made the drug less expensive for patients, enhancing accessibility for coping with hypertension. However, the upward push of standard options additionally intensifies marketplace competition, which could impact the pricing strategies of pharmaceutical businesses. As more manufacturers produce typical enalapril, the competition drives down prices, setting stress on the earnings margins for authentic logo manufacturers. While this benefits customers via decreased costs, it challenges corporations to hold profitability and marketplace share in increasingly more competitive surroundings, pushing them to innovate or diversify their product portfolios to live aggressively.
The Rising Utilization of Combination Therapies for Hypertension and Heart Failure: Enalapril, classified as an ACE inhibitor, is experiencing an increasing demand as part of combination therapies aimed at managing chronic conditions such as hypertension and congestive heart failure. Physicians are progressively prescribing Enalapril in conjunction with diuretics or calcium channel blockers to enhance treatment effectiveness and minimize side effects. This trend is propelled by a heightened awareness of comprehensive cardiovascular care and the necessity for personalized treatment strategies. Given that cardiovascular diseases represent a significant global health issue, particularly among aging populations, Enalapril continues to be a vital element in multi-drug regimens designed for long-term risk mitigation and improved patient outcomes.
Growth in Generic Drug Markets in Developing Nations: With the expiration of patents on branded Enalapril products, generic alternatives are becoming increasingly popular, especially in developing nations where affordable treatment options are essential. Governments and healthcare providers are advocating for the use of cost-effective generics to enhance access to vital medications. This movement is bolstered by expanding public health initiatives focused on hypertension and heart disease in areas such as Asia, Africa, and Latin America. As regulatory approvals increase and local manufacturing capabilities expand, the availability of generic Enalapril is anticipated to rise, promoting broader market penetration and enhancing healthcare accessibility.
The COVID-19 pandemic had a blended impact on the enalapril market. On the one hand, disruptions inside the global delivery chain and healthcare systems affected drug manufacturing and distribution, leading to transient shortages. Lockdowns and hospital useful resource prioritization additionally behind schedule ordinary medical visits, decreasing new prescriptions for high blood pressure. However, the pandemic highlighted the importance of handling comorbid situations like cardiovascular sicknesses, as sufferers with high blood pressure were more susceptible to extreme COVID-19 consequences. This strengthened the want for medicines like enalapril, main to a steady demand post-pandemic as healthcare systems stabilized and attention on continual ailment control resumed.
We have various report editions of Enalapril Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
The enalapril market's aggressive panorama capabilities several key players, consisting of essential pharmaceutical businesses and standard manufacturers. Competition is pushed by way of elements together with pricing, product availability, and marketplace proportion. The upward thrust of ordinary enalapril has intensified rate opposition, while businesses recognize innovation, branding, and partnerships to distinguish themselves and maintain profitability in a fee-sensitive market.
Top Companies Market Share in Enalapril Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the Enalaprils market, and the region is expected to have significant growth during the projected period. The enalapril marketplace in North America is experiencing a boom due to the growing prevalence of high blood pressure and cardiovascular diseases. Increased recognition of health risks, early prognosis, and the availability of less expensive conventional alternatives are driving the call for enalapril, making it a crucial component of high blood pressure management within the area.
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The enalapril marketplace within the Asia Pacific region is increasing because of rising hypertension charges and increasing healthcare rights of entry. Growing cognizance of cardiovascular fitness, coupled with a shift in the direction of preventive care and early diagnosis, is riding demand for enalapril, positioning it as a key treatment alternative inside the market.
The current report Scope analyzes Enalapril Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Enalapril market size was estimated at USD xx Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.
According to Cognitive Market Research, the global Enalapril market size was estimated at USD xx Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.
According to Cognitive Market Research, the global Enalapril market size was estimated at USD xx Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
According to Cognitive Market Research, the global Enalapril market size was estimated at USD xx Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.
According to Cognitive Market Research, the global Enalapril market size was estimated at USD xx Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031..
Global Enalapril Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Enalapril Industry growth. Enalapril market has been segmented with the help of its Dosage Form O, Application Distribution Channel, and others. Enalapril market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Enalapril Market?
According to Cognitive Market Research, Oral Tablets are likely to dominate the Enalapril Market over the forecast period. The oral pill section of the enalapril market is developing due to its convenience, ease of administration, and effectiveness in dealing with hypertension. Increasing affected persons' choice for oral medicinal drugs and the availability of diverse dosages are riding demand, making enalapril capsules a famous choice for both sufferers and healthcare companies.
The Oral Solution is the fastest-growing segment in the Enalapril Market. The oral solution section of the enalapril market is experiencing an increase, specifically among patients who've difficulty swallowing pills. This formulation gives flexibility in dosing, making it appropriate for pediatric and aged populations. Increased recognition and demand for tailor-made treatment alternatives are using the adoption of enalapril oral solutions.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Enalapril Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the Hypertension segment holds the largest share of the market. The growing prevalence of hypertension is appreciably riding the enalapril marketplace. Increased awareness of cardiovascular fitness, lifestyle changes, and growing older populations contribute to extra diagnoses and treatments. As healthcare vendors emphasize powerful control of hypertension, enalapril remains a desired preference, bolstering its market call for in this therapeutic vicinity.
In the Enalapril Market, the Congestive Heart Failure has been expanding at a rapid pace. The growing prevalence of congestive coronary heart failure (CHF) is fueling growth in the enalapril marketplace. As healthcare professionals recognize effective remedies for CHF, enalapril's ability to reduce signs and symptoms and enhance patient effects makes it a desired remedy. This fashion displays a broader commitment to managing cardiovascular illnesses correctly.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, Retail Pharmacy segment holds the largest market share. The retail pharmacy region is driving the increase in the enalapril market because of extended accessibility and comfort for sufferers. With a rise in high blood pressure and coronary heart failure diagnoses, retail pharmacies play a critical role in offering less costly medicinal drugs, fostering patient adherence, and promoting attention to cardiovascular health control alternatives. .
In the Enalapril market, the rapidly growing sector is Hospital Pharmacy. The medical institution pharmacy segment is contributing to the boom of the enalapril marketplace, driven by the increasing admission charges of patients with high blood pressure and heart failure. Hospitals prioritize effective treatment alternatives, and enalapril's validated efficacy enhances patient care, leading to its extra usage in scientific settings and inpatient control.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Dosage Form O | Oral Tablets, Oral Solution |
Application | Hypertension, Congestive Heart Failure, Other applications |
Distribution Channel | Retail Pharmacy, Hospital Pharmacy, E-commerce Websites, Online Drug Stores |
List of Competitors | Mylan Pharmaceuticals, Hikma Farmaceutica, Pfizer, CSPC, Taro Pharmaceuticals, Dexcel Pharma, Accord Healthcare, Chenxin Pharmaceutical, Apotex Inc, Watson Pharma, Lek Pharmaceuticals |
This chapter will help you gain GLOBAL Market Analysis of Enalapril. Further deep in this chapter, you will be able to review Global Enalapril Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Enalapril. Further deep in this chapter, you will be able to review North America Enalapril Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Enalapril. Further deep in this chapter, you will be able to review Europe Enalapril Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Enalapril. Further deep in this chapter, you will be able to review Asia Pacific Enalapril Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Enalapril. Further deep in this chapter, you will be able to review South America Enalapril Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Enalapril. Further deep in this chapter, you will be able to review Middle East Enalapril Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Enalapril. Further deep in this chapter, you will be able to review Middle East Enalapril Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Enalapril. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Dosage Form O Analysis 2019 -2031, will provide market size split by Dosage Form O. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Dosage Form O Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Distribution Channel Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Enalapril market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 14 Research Methodology and Sources
Why Oral Tablets have a significant impact on Enalapril market? |
What are the key factors affecting the Oral Tablets and Oral Solution of Enalapril Market? |
What is the CAGR/Growth Rate of Hypertension during the forecast period? |
By type, which segment accounted for largest share of the global Enalapril Market? |
Which region is expected to dominate the global Enalapril Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|